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The Global initiative for Chronic Obstructive Lung Disease (GOLD) staging has widely used in the stratiﬁcation of the severity
of COPD, while BODE (body mass index, airﬂow obstruction, dyspnea, and exercise capacity) index was proven superior to
FEV1 in predicting mortality, exacerbation and disease severity in patients with COPD. Clinical COPD Questionnaire (CCQ),
a questionnaire with ten items categorized into three domains (symptoms, functional state and mental state) was developed to
measure health status of COPD patients. However, little is known about the relationship between CCQ score and BODE index.
We performed a prospective study with the inclusion of 89 patients who were clinically stable after a 6-week-therapy for COPD
symptomscomparingtheirhealthstatusassessedbyCCQ,BODEindexandGOLDstaging.WefoundthatthetotalCCQscorewas
correlated with BODE score (P<0.001) and GOLD staging (P<0.001); of three CCQ domains, the functional status correlated
the most with BODE index (rS = 0.670) and GOLD staging (rS = 0.531), followed by symptoms (rS = 0.482; rS = 0.346,
respectively), and mental status (rS = 0.340; rS = 0.236, respectively). Our data suggest that CCQ is a reliable and convenient
alternative tool to evaluate the severity of COPD.
1.Introduction
Chronic obstructive pulmonary disease (COPD) is a disease
state characterized by nonfully reversible airﬂow limitation.
The airﬂow limitation is usually progressive and associated
with an abnormal inﬂammatory response of the lungs to
noxious particles or gases [1]. Conventionally, a forced expi-
ratory volume in the ﬁrst second (FEV1) and a low FEV1/
forced vital capacity (FVC) ratio are used to grade the severi-
ty of COPD, and the Global Initiative for Chronic Obstruc-
tive Lung Disease (GOLD) deﬁnition for airﬂow limitation is
aFEV1/FVCratiooflessthan70%[1].However,thesystemic
manifestations of COPD were not necessarily fully reﬂected
by FEV1/FVC in clinical practice [2–6]. BODE index, a
multidimensional parameter including the body-mass index
(B), the degree of airﬂow obstruction (O), functional dysp-
nea(D),andexercisecapacity(E),wasproposedbyCellietal.
[2] and was reported to be superior to FEV1 in reﬂecting the
severity of COPD and eﬀective in predicting the mortality in
patients with COPD [2]. BODE index was also reported to
be applicable in predicting an individual’s need for hospital-
ization [7], measuring follow-up lung functional change in
pulmonary rehabilitation [8] as well as transbronchoscopic
placement of one-way valves [9], predicting the survival after
a patient receiving lung volume reduction surgery [10]a n d
reﬂecting the disease modiﬁcation [11].
Since 1948, whenthe World HealthOrganization deﬁned
health as being not only the absence of disease and inﬁrmity
but also the presence of physical, mental, and social well-
being, quality of life has been considered ever increasingly2 The Scientiﬁc World Journal
important in healthcare practice and research [12]. Based
on validated evidence [13–16], in 2003, the Clinical COPD
Questionnaire (CCQ) was developed to measure health
status of COPD patients [17–20]. The CCQ is a short health
status questionnaire with ten items that are categorized into
three domains, namely, symptoms, functional state, and
mental state. The grading of measurements of CCQ was
proven to be a function of changes in symptom severity in
patients with COPD and in patients at risk for COPD, and
reliable in discriminating between groups of patients that
diﬀer in severity of COPD [13]. One of the primary aims in
the development of the CCQ was to create a scale capable of
measuring changes in health status (e.g., changes of pre- and
postintervention health status in the patients in question).
Theminimal clinicallyimportant diﬀerenceof thetotal CCQ
score is 0.4, which is used to judge whether a particular
changeinscorerepresentsasigniﬁcantimprovementordete-
rioration, or whether it represents a trivial change [21].
BODE index was reported to be good at predicting the
worsening of health-related quality of life in COPD patients
as measured by the St. George’s Respiratory Questionnaire
(SGRQ)ofwhichtheevaluationislimitedtothesubdomains
of subjective symptoms and subjective impairment [22–24].
CCQ score helps clinicians identify not only the clinical sta-
tus of the airway but also activity limitations and emotional
dysfunction in the patients with COPD. However, little is
known about the correlation of CCQ score and BODE index
intermsofmeasurementofqualityoflifeintheclinicallysta-
ble COPD patients. This study aimed to elucidate this infor-
mation by comparing the status of COPD patients measured
by CCQ and those measured by 2 diﬀerent schemes: the
GOLD classiﬁcation criteria and the BODE index.
2. Methods
2.1. Study Design. A prospective study was conducted to in-
vestigate the association between the Clinical COPD Ques-
tionnaire (CCQ) and COPD severity assessed by two criteria:
the GOLD staging and the BODE index.
2.2. Study Subjects. Between August 2005 and July 2006, a
total of 89 patients with a wide range of symptom severity
of COPD were recruited into a prospective study from the
outpatient clinic of the Division of Pulmonary Medicine,
Kaohsiung Chang Gung Memorial Hospital, a 2300-bed
facility serving as a primary care and tertiary referral center
in Taiwan. This study was approved by the Institutional
Review Board of the research hospital. Each recruited COPD
patient (aged ≥ 40 years and with written consent) was
a heavy smoker who had an at least 10-pack-year history
of smoking. The diagnosis of COPD was made based on
the GOLD criteria: FEV1/FVC < 0.7 and reversibility to
inhaled bronchodilator in FEV1 < 15% [25]. Other causes of
airﬂow limitation such as pulmonary tuberculosis, bronchial
asthma,bronchiectasis,andheartfailurewereexcludedinthe
enrolled patients by reviewing their chest radiographs and
medical histories. After a 6-week appropriate therapy, the
clinically stable COPD patients were included and subjected
to calculation of BODE index and measurement with CCQ.
Patients who were experiencing exacerbation of COPD (e.g.,
presence of fever, increased purulent sputum, and dyspnea)
or were hospitalized for whateverreasons during the 6-week-
therapy period were excluded from this study.
2.3. Assessment with BODE Index. The calculation of BODE
index was carried out using an empirical model as previously
described [2]. Speciﬁcally, the degree of airﬂow obstruction
was measured by FEV1, dyspnea by the modiﬁed Medical
Research Council (MMRC) dyspnea scale [26], and exer-
cise capacity by the distances of the six-minute-walk test
(6MWD) [27]. For each value of FEV1, MMRC dyspnea
scale, 6MWD, the patients received points ranging from 0 to
3; for body mass index, the point was either 0 or 1 [2]. The
points for each BODE component in each included patient
were added, so that the BODE index ranged from 0 to 10
points for each individual. The BODE score was further
quartilized as follows: quartile 1 (a score of 0 to 2 points),
quartile 2 (a score of 3 to 4 points), quartile 3 (a score of 5 to
6p o i n t s ) ,a n dq u a r t i l e4( as c o r eo f7t o1 0p o i n t s )[ 2].
2.4. Assessment with CCQ. Measurement of health status of
the included patients was performed using the copyrighted
CCQ (see the appendix) [13], with the approval from
Professor van der Molen Thys. The CCQ consists of ten
items (questions), which are allocated in the following three
domains: symptoms (items 1, 2, 5, and 6), functional state
(items 7, 8, 9, and 10), and mental state (items 3 and
4). Each CCQ item in this study is presented as CCQn,
where n is the number corresponding to the numeric order
of the question in CCQ. The enrolled patients were asked
to record their experiences in the seven days immediately
before measurement of their health status in a week-version
CCQ. The CCQ total score and the CCQ domain scores
were derived from dividing the sum of graded points for
each related question by the number of questions [13]. The
CCQ total score and the CCQ domain scores varied between
0 (indicating very good health status) to 6 (indicating
extremely poor health status). The CCQ was completed by
eachincluded patientathisoutpatientvisitandwasreturned
toastudycoordinator.Toavoidconfounding,thesamestudy
coordinator was designated throughout this study.
2.5. Statistical Analyses. Continuous variables are presented
as mean ± SD and categorical variables as absolute number
and percentage. Spearman’s rank correlation test was per-
formed to measure how closely the COPD assessed by CCQ
score agreed with that by GOLD classiﬁcation and that by
the BODE index. Comparison of mean CCQ scores/CCQ
domain scores in diﬀerent GOLD stages and BODE index
quartiles was performed by one-way ANOVA. A 2-sided
value of P<0.05 was considered statistically signiﬁcant.
Statistical analyses were performed using the SPSS software
package, version 11.5 (SPSS Inc., Chicago, IL, USA).The Scientiﬁc World Journal 3
Table 1: Characteristics of 89 included men with clinically stable
chronic obstructive pulmonary disease.
Characteristic Mean ± SD
Age (yr) 70.6 ±10.1
Male (%) 80.1 ±0.2
Smoking history (pack-yr) 51.8 ± 28.2
FVC∗ (liter) 70.9 ±18.9
FEV1/FVC† 55.4 ±11.9
FEV1 (% of predicted value) 54.2 ±21.7
MMRC dyspnea scale‡ 1.9 ± 1.4
Distance walked in 6min (m) 398.4 ±115.2
Body mass index§ 23.4 ± 3.5
∗FVC denotes forced vital capacity, and †FEV1 forced expiratory volume in
one second. ‡Scores on the modiﬁed Medical Research Council (MMRC)
dyspnea scale may range from 0 to 4, with a score of 4 indicating that the
patient is too breathless to leave the house or becomes breathless when
dressing or undressing. §The body mass index is the weight in kilograms
divided by the square of the height in meter.
3. Results
3.1. Characteristics of Study Subjects, Severity of COPD
Measured with FEV1, FEV1/FVC, BODE Index Score, and
CCQ Scores. A total of 89 clinically stable COPD patients
were included for analyses (Table 1). The severity of COPD
byGOLDclassiﬁcation, BODEindex, andBODEquartilesof
the included patients are detailed in Table 2. The CCQ total
score, CCQ domain scores, and CCQ item scores are shown
in Table 3.
3.2. Correlations of CCQ Scores and the Stratiﬁed COPD
Severities by GOLD Criteria. Statistically signiﬁcant correla-
tion was found between the CCQ total scores/CCQ function
scores and the stratiﬁed COPD severities (P<0.001),
between CCQ symptom score and the stratiﬁed COPD
severities (P = 0.001), and between CCQ mental score and
the stratiﬁed COPD severities (P = 0.03) (Figure 1). Mean
CCQ total scores/mean CCQ domain scores corresponding
to the stratiﬁed COPD severities (stages I–IV) by GOLD
criteria were as follows. Mean CCQ total scores were 1.33
(stage I), 1.58 (stage II), 2.63 (stage III), and 2.54 (stage IV).
Mean CCQ function scores were 0.9 (stage I), 1.26 (stage II),
2.38 (stage III), and 3.00 (stage IV). Mean CCQ symptom
scores were 1.67 (stage I), 2.07 (stage II), 2.91 (stage III), and
2.64 (stage IV). Mean CCQ mental scores were 1.54 (stage I),
1.22 (stage II), 2.58 (stage III), and 1.44 (stage IV).
3.3. Correlation of CCQ Scores and COPD Severity by the
BODE Index. Statistically signiﬁcant correlation was found
between the CCQ total scores/CCQ function scores/CCQ
symptom scores and the COPD severity by the BODE index
(P<0.001) and between CCQ mental scores and BODE
quartiles (P = 0.001) (Figure 2). The mean CCQ total
scores/CCQ domain scores corresponding to the BODE
quartiles (quartiles I-IV) were as follows. Mean CCQ total
scores were 1.33 (quartile I), 2.26 (quartile II), 2.78 (quartile
III), and 3.1 (quartile IV). Mean CCQ function scores were
Table 2: GOLD stages of chronic obstructive pulmonary disease
(COPD), BODE index score, and BODE quartiles in the 89 COPD
patients.
Characteristic Number of
patients (%)
COPD GOLD stage
Stage I (FEV1∗ > 80% of predicted value) 12 (13.5)
Stage II (FEV1, 50–80% of predicted value) 36 (40.4)
Stage III (FEV1, 30–50% of predicted value) 32 (36)
Stage IV (FEV1 ≤ 30% of predicted value) 9 (10.1)
BODE index†
0 15 (16.9)
1 16 (18.0)
2 11 (12.4)
3 10 (11.2)
4 9 (10.1)
5 12 (13.5)
6 6 (6.7)
7 6 (6.7)
8 2 (2.2)
9 2 (2.2)
10 0( 0 )
BODE quartile‡
1 42 (47.2)
2 19 (21.3)
3 18 (20.2)
4 10 (11.2)
∗FEV1 denotes forced expiratory volume in one second. †See text for details
ofBODE;thehighertheBODEindex,thegreatertheriskofdeath. ‡Quartile
1r e f e r r e dt oB O D Es c o r eo f0t o2 ,q u a r t i l e2t o3t o4 ,q u a r t i l e3t o5t o6 ,
and quartile 4 to 7 to 10.
1.00 (quartile I), 1.81 (quartile II), 2.60 (quartile III), and
3.60 (quartile IV). Mean CCQ symptom scores were 1.74
(quartile I), 2.62 (quartile II), 3.21 (quartile III), and 3.60
(quartile IV).
3.4. Correlation between CCQ Score and the BODE
Index/GOLD Staging. The correlations of the total CCQ
scores/CCQ domain scores with the BODE index and GOLD
classiﬁcation in assessment of severity of COPD and the
Spearmancorrelationcoeﬃcients(rS)aredetailedinTable 4.
The CCQ functional scores correlated most with the BODE
index (rS = 0.670) and GOLD classiﬁcation (rS = 0.531),
followed by the CCQ total scores. The CCQ total scores and
each CCQ domain score were better correlated with the
BODE index than with GOLD classiﬁcation.
4. Discussion
Our data demonstrated that CCQ scores had a good correla-
tionwiththeBODEindexandGOLDclassiﬁcationinassess-
ing the severity of COPD. The robust correlation between
CCQ scores and the BODE index, a documented practical4 The Scientiﬁc World Journal
Table 3: Scores of Clinical COPD Questionnaire score (CCQ) and
those of its components in 89 patients with clinically stable chronic
obstructive pulmonary disease.
Variable Score (mean ± SD)
CCQ item∗
CCQ1 1.16 ± 1.36
CCQ2 3.30 ± 2.03
CCQ3 1.93 ± 1.70
CCQ4 1.62 ± 1.50
CCQ5 2.58 ± 1.81
CCQ6 2.46 ± 1.68
CCQ7 2.89 ± 1.58
CCQ8 2.43 ± 1.63
CCQ9 1.26 ± 1.51
CCQ10 0.58 ± 1.05
CCQ domain
Symptoms 2.38 ± 1.37
Functional status 1.79 ± 1.31
Mental status 1.78 ± 1.49
CCQ total score 2.02 ± 1.16
∗An individual CCQ item refers to one individual question in CCQ (see
appendixfordetails),andtheseitemswereallocatedinoneofthethreeCCQ
domains as follows: symptoms (items 1, 2, 5, and 6), functional state (items
7, 8, 9, and 10), and mental state (items 3 and 4).
instrument in predicting the severity and mortality in this
patient population, suggests that it is reasonable to use CCQ
as an alternative in the assessment of life quality of COPD
patients.
When it comes to the correlation strength with BODE
score, the CCQ domain scores/CCQ total score in decreasing
order were CCQ functional score (rS = 0.670), CCQ total
score (rS = 0.610), CCQ symptom score (rS = 0.482),
and CCQ mental score (rS = 0.340). The CCQ functional
domain aims at assessing limitations of activities because of
the breathing problems, which includes four items: CCQ7
(strenuous physical activities), CCQ8 (moderate physical
activities), CCQ9 (daily activities at home), and CCQ10
(social activities) (see the appendix for details). CCQ7-9
describes the extent of breathing problem during diﬀerent
degrees of activity, representing not only a patient’s res-
piratory condition (FEV1), perception (MMRC), exercise
capacity(6MWD).Ofnote,CCQ10isasurrogateofcomplex
parameters not only for physical activities, but also for
socioeconomic activities; it is therefore not surprising that
CCQ10 was correlated with MMRC, FEV1, and BMI.
The CCQ mental domain includes 2 items, namely,
CCQ3 (concern about getting a cold or breathing get-
ting worse?) and CCQ4 (depression because of breathing
problems?), and, when comparing to other CCQ domains,
CCQ mental domain was found to have weaker correlation
with BODE index and GOLD classiﬁcation. The CCQ
mental score reﬂects psychological and subjective feelings
of the patient, which are developed based on the personal
experience, socioeconomic status, and attitude toward life.
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Figure 1:BoxplotforCCQscoresbyGOLDclassiﬁcation(FEV1%
predicted). Error bars show standard deviation and horizontal lines
within boxes show the mean for CCQ scores.
COPD is a systemic disease that is associated with systemic
inﬂammation and skeletal muscle dysfunction [28–31].
Thesesystemiceﬀectsleadtodeclineinhealthstatus,exercise
de-conditioning, relative social isolation, and development
of depressive mood, muscle wasting, and weight loss in the
patients with COPD. The above-mentioned adverse factors
form a vicious cycle in which depression is possibly further
aggravated.
Because the complexity of CODP expresses itself in res-
piratory, perceptive, and systemic aspects [2], it is impossible
to use the conventionally employed physiological variable
FEV1 alone to depict each perspective and measure the
severity of COPD. For example, FEV1 is weakly correlated
with the degree of dyspnea [3], and the change in FEV1
fails to reﬂect the rate of decline in patients’ health status
[4]. The degrees of dyspnea [5] and health status scores [6]
were reported to be more accurate than FEV1 in predicting
the risk for death in patients with COPD. Therefore, new
GOLD guidelines were announced in the annual meeting
of Asia-Paciﬁc Society of Respirology in November 2011 in
Shanghai and suggested the assessment of the severity of
COPD not only by FEV1 alone, but also by symptom scoring
(e.g., MMRC dyspnea scale or CAT score) and the frequency
of acute exacerbation of COPD. These conceptual changes
in the GOLD guidelines underscore the important role of
a good questionnaire in assessing the severity of COPD in
clinical practice.
BODE score has a high value in evaluating COPD sever-
ity and predicting mortality of the aﬀected patients [2].
However, calculation of BODE index requires collectionThe Scientiﬁc World Journal 5
Table 4: Spearman correlation between CCQ scores and the BODE index/GOLD classiﬁcation in assessment of severity of COPD.
CCQ BODE index GOLD classiﬁcation
Correlation coeﬃcient (rS) P Correlation coeﬃcient (rS) P
CCQ symptom scores 0.482 <0.001 0.346 0.001
CCQ functional scores 0.670 <0.001 0.531 <0.001
CCQ mental scores 0.340 0.001 0.236 0.026
CCQ total scores 0.610 <0.001 0.462 <0.001
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Figure 2: Box plot for CCQ scores by BODE quartiles. Error bars
showstandarddeviation andhorizontallines withinboxes showthe
mean for CCQ scores.
of information regarding body weight as well as body
length and data generated from spirometric and 6-minute
walking tests. Spirometric and 6-minute walking tests are
relatively time consuming, comparatively costly, and require
the necessary equipments and involvement of qualiﬁed staﬀ
(e.g., chest physician and technician). As a result, the appli-
cability of BODE index sometimes has been limited by the
widespreadresource-deﬁciencysettingssuchaspractitioner’s
clinics and facilities situated in remote rural areas. In the
scenario that collection of data for calculation of BODE
is possible, it is inconvenient for the patient in question
because it is not until the following visit will he/she know
the results of BODE assessment. In contrast, assessment
of clinical severity of COPD with CCQ needs neither data
generated from time-consuming process nor labor-intensive
tests. CCQ is easy to complete by the patients themselves
at their outpatient visits. Furthermore, the convenience of
applicability of serial CCQ in follow-up evaluation makes
detection of changes in severity of COPD more rapidly and
eﬀectively, and thus necessary intervention may start in a
more timely fashion. However, this does not imply that CCQ
can substitute BODE.
Some limitations in our study should be addressed.
First, this study is only a cross-section study; longitudinal
follow-up studies on outcomes concerning the frequencies
of subsequent hospitalization and COPD acute exacerbation
and mortality are needed to better measure the correlation
between CCQ and the BDE index. Second, the numbers of
patientsincludedinthisstudyweresmallandthepatientsare
of the same race; COPD patients of diﬀerent races may have
diﬀerent outcomes. Third, our data might be biased by the
single medical-center-based patients rather than population-
based patients included.
In conclusion, CCQ scores have a good correlation with
BODE index and GOLD staging and CCQ scores correlate
better with BODE index than GOLD staging in our cross-
sectional study. However, whether CCQ score correlates with
BODE index in a longitudinal study or nonhospital-based
population or not needs further investigations.
Appendix
The Clinical COPD Questionnaire (CCQ) [18] contains 10
items (CCQn, where n is the numeric order ranging from
1–10). Patients were instructed to recall their experiences
during the p previous week (week-version CCQ) regarding
on average, how often did they feel short of breath at rest?
(CCQ1), short of breath doing physical activities? (CCQ2),
concerned about getting a cold or breathing problems?
(CCQ3), and depressed (down) because of breathing prob-
lems? (CCQ4); in general, how much of the time did they
cough? (CCQ5), and did they produce phlegm? (CCQ6); on
average, how limited were they in the following activities
because of their breathing problems: strenuous physical
activities(CCQ7),moderatephysicalactivities(CCQ8),daily
activities at home (CCQ9), and social activities (CCQ10).
Eachpatient responded to eachof CCQn witha 7-point scale
ranging from 0 (indicating asymptomatic/no limitation) to
6 (indicating extremely symptomatic/totally limited). Calcu-
lation of scores were as follows: CCQ total score = (CCQ1 +
2+3+4+5+6+7+8+9+1 0 )/ 1 0 ;C C Qsym pt o msc o r e=
(CCQ1 + 2 + 5 + 6)/4; CCQ function score = ( C C Q 7+8+
9 + 10)/4; CCQ mental state score = (CCQ3 + 4)/2.
Abbreviations
FEV1: Forced expiratory volume in the ﬁrst second
CCQ: The Clinical COPD Questionnaire6 The Scientiﬁc World Journal
COPD: Chronic obstructive pulmonary disease
BODE: Body mass index (B), the degree of airﬂow
obstruction (O), functional dyspnea (D),
and exercise capacity (E)
MMRC: The modiﬁed Medical Research Council
6MWD: The distances of the six-minute-walk test.
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